echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Wan Gang: The sixth round of China-US Science and Technology Innovation Dialogue includes four topics including biopharmaceutical cooperation

    Wan Gang: The sixth round of China-US Science and Technology Innovation Dialogue includes four topics including biopharmaceutical cooperation

    • Last Update: 2014-07-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: great wisdom astak news agency July 10, 2014 according to a briefing by Wan Gang, Minister of science and technology on Thursday noon, this morning, the sixth round of China US strategic and Economic Dialogue held a dialogue on science and technology innovation, involving issues such as biopharmaceutical innovation cooperation, with the participation of officials, experts and enterprises from the science and technology departments of China and the United States Wan Gang said that there are four important issues in this round of dialogue on scientific and technological innovation First, in response to the reform of science and technology innovation industry since the financial crisis, both governments have set up some cross sector projects for the future, and how to coordinate these projects The United States cited nanotechnology and brain science and technology, while China cited new pharmaceutical technology Both sides agreed on the need to play the role of enterprises and markets Second, how to jointly build an ecological system of innovation and cooperation for Biopharmaceutical Enterprises Both sides are carrying out the reform of medical system How to provide effective drugs with high efficiency and low price is very important Both sides have a deep cooperation in basic scientific research and enterprise cooperation, and both of them take enterprises as the main body The FDA and CFDA of the United States proposed to speed up the process of clinical drug approval, and both departments gave positive responses Third, intelligent infrastructure construction in the process of urbanization, such as cooperation in the fields of smart grid, intelligent transportation, charging facilities and electric vehicles Through the speeches of experts and enterprises, especially automobile enterprises, it is recognized that the development of electric vehicles in China and the United States is very fast There are more than 100000 electric vehicles in the United States and 70000 electric vehicles in China To promote private use of electric vehicles, infrastructure is very important, such as charging facilities, which need policy support Yesterday, the State Council discussed the issue of tax reduction and exemption for electric vehicles, how to coordinate the relationship between the construction of charging piles and car owners, and how to innovate the business model Fourth, promote the cooperation between small and medium-sized enterprises and high-tech enterprises.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.